1	Nasal	nasal	_	_	_	_	_	_	_
2	NK-	NK-	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	T-cell	T-cell	_	_	_	_	_	_	_
5	lymphomas	lymphoma	_	_	_	_	_	_	_
6	share	share	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	same	same	_	_	_	_	_	_	_
9	type	type	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	latency	latency	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	nasopharyngeal	nasopharyngeal	_	_	_	_	_	_	_
16	carcinoma	carcinoma	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	Hodgkin	Hodgkin	_	_	_	_	_	_	_
19	’s	's	_	_	_	_	_	_	_
20	disease	disease	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Nasal	nasal	_	_	_	_	_	_	_
2	T/NK-cell	T/NK-cell	_	_	_	_	_	_	_
3	lymphomas	lymphoma	_	_	_	_	_	_	_
4	can	can	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	further	further	_	_	_	_	_	_	_
7	separated	separate	_	_	_	_	_	_	_
8	into	into	_	_	_	_	_	_	_
9	those	those	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	natural	natural	_	_	_	_	_	_	_
12	killer	killer	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	NK	NK	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	lineage	lineage	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	T-cell	t-cell	_	_	_	_	_	_	_
21	lineage	lineage	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	differences	difference	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	cellular	cellular	_	_	_	_	_	_	_
27	phenotype	phenotype	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	T-cell	t-cell	_	_	_	_	_	_	_
30	receptor	receptor	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	TcR	TcR	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	gene	gene	_	_	_	_	_	_	_
35	rearrangement	rearrangement	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	TcR	tcr	_	_	_	_	_	_	_
38	transcript	transcript	_	_	_	_	_	_	_
39	expression	expression	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	NK-	nk-	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	T-cell	t-cell	_	_	_	_	_	_	_
5	subtypes	subtype	_	_	_	_	_	_	_
6	are	be	_	_	_	_	_	_	_
7	closely	closely	_	_	_	_	_	_	_
8	associated	associate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
11	virus	virus	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	EBV	EBV	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	EBV	EBV	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	determined	determine	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	23	23	_	_	_	_	_	_	_
12	cases	case	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	nasal	nasal	_	_	_	_	_	_	_
15	lymphoma	lymphoma	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	NL	NL	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	situ	situ	_	_	_	_	_	_	_
22	hybridisation	hybridisation	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	ISH	ISH	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	reverse	reverse	_	_	_	_	_	_	_
28	transcriptase-polymerase	transcriptase-polymerase	_	_	_	_	_	_	_
29	chain	chain	_	_	_	_	_	_	_
30	reaction	reaction	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	RT-PCR	RT-PCR	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	immunohistochemistry	immunohistochemistry	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	IH	IH	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Of	of	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	23	23	_	_	_	_	_	_	_
4	cases	case	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	19	19	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	classified	classify	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	NK-cell	NK-cell	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	4	4	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	T-cell	t-cell	_	_	_	_	_	_	_
15	tumours	tumour	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	ISH	ish	_	_	_	_	_	_	_
2	for	for	_	_	_	_	_	_	_
3	EBV-encoded	ebv-encoded	_	_	_	_	_	_	_
4	small	small	_	_	_	_	_	_	_
5	non-polyadenylated	non-polyadenylated	_	_	_	_	_	_	_
6	RNAs	rna	_	_	_	_	_	_	_
7	showed	show	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	all	all	_	_	_	_	_	_	_
10	cases	case	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	whether	whether	_	_	_	_	_	_	_
13	NK	NK	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	harboured	harbour	_	_	_	_	_	_	_
18	EBV	EBV	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	virtually	virtually	_	_	_	_	_	_	_
21	all	all	_	_	_	_	_	_	_
22	tumour	tumour	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	RT-PCR	RT-PCR	_	_	_	_	_	_	_
2	demonstrated	demonstrate	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	NL	NL	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	subtypes	subtype	_	_	_	_	_	_	_
8	expressed	express	_	_	_	_	_	_	_
9	EBNAI	EBNAI	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	QUK	QUK	_	_	_	_	_	_	_
13	splice	splice	_	_	_	_	_	_	_
14	pattern	pattern	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	latent	latent	_	_	_	_	_	_	_
18	membrane	membrane	_	_	_	_	_	_	_
19	proteins	protein	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	LMP1	LMP1	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	2	2	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	BamHI	BamHI	_	_	_	_	_	_	_
27	A	a	_	_	_	_	_	_	_
28	rightward	rightward	_	_	_	_	_	_	_
29	transcripts	transcript	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	absence	absence	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	EBNA2	ebna2	_	_	_	_	_	_	_
35	mRNAs	mrna	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	compatible	compatible	_	_	_	_	_	_	_
38	with	with	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	latency	latency	_	_	_	_	_	_	_
41	type	type	_	_	_	_	_	_	_
42	II	ii	_	_	_	_	_	_	_
43	pattern	pattern	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	EBV	EBV	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	IH	IH	_	_	_	_	_	_	_
11	revealed	reveal	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	heterogeneous	heterogeneous	_	_	_	_	_	_	_
14	pattern	pattern	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	EBV	EBV	_	_	_	_	_	_	_
17	gene	gene	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	single-cell	single-cell	_	_	_	_	_	_	_
22	level	level	_	_	_	_	_	_	_
23	consisting	consist	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	both	both	_	_	_	_	_	_	_
26	LMP1+	lmp1+	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	LMP1-	lmp1-	_	_	_	_	_	_	_
29	tumour	tumour	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	suggesting	suggest	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	mixture	mixture	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	latency	latency	_	_	_	_	_	_	_
37	I	i	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	II	ii	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	2	2	_	_	_	_	_	_	_
3	early	early	_	_	_	_	_	_	_
4	lytic	lytic	_	_	_	_	_	_	_
5	transcripts	transcript	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	BZLF1	BZLF1	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	BHRF1	BHRF1	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	detected	detect	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	13	13	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	10	10	_	_	_	_	_	_	_
18	cases	case	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	respectively	respectively	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	lack	lack	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	ZEBRA	ZEBRA	_	_	_	_	_	_	_
26	staining	staining	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	any	any	_	_	_	_	_	_	_
29	case	case	_	_	_	_	_	_	_
30	indicates	indicate	_	_	_	_	_	_	_
31	that	that	_	_	_	_	_	_	_
32	these	these	_	_	_	_	_	_	_
33	lytic	lytic	_	_	_	_	_	_	_
34	transcripts	transcript	_	_	_	_	_	_	_
35	are	be	_	_	_	_	_	_	_
36	most	most	_	_	_	_	_	_	_
37	likely	likely	_	_	_	_	_	_	_
38	expressed	express	_	_	_	_	_	_	_
39	by	by	_	_	_	_	_	_	_
40	rare	rare	_	_	_	_	_	_	_
41	cells	cell	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	the	the	_	_	_	_	_	_	_
44	biopsies	biopsy	_	_	_	_	_	_	_
45	entering	enter	_	_	_	_	_	_	_
46	lytic	lytic	_	_	_	_	_	_	_
47	cycle	cycle	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	viral	viral	_	_	_	_	_	_	_
3	transcriptional	transcriptional	_	_	_	_	_	_	_
4	pattern	pattern	_	_	_	_	_	_	_
5	similar	similar	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	nasopharyngeal	nasopharyngeal	_	_	_	_	_	_	_
10	carcinoma	carcinoma	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	Hodgkin	Hodgkin	_	_	_	_	_	_	_
13	’s	's	_	_	_	_	_	_	_
14	disease	disease	_	_	_	_	_	_	_
15	suggests	suggest	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	EBV	EBV	_	_	_	_	_	_	_
18	can	can	_	_	_	_	_	_	_
19	exploit	exploit	_	_	_	_	_	_	_
20	common	common	_	_	_	_	_	_	_
21	regulatory	regulatory	_	_	_	_	_	_	_
22	mechanisms	mechanism	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	gene	gene	_	_	_	_	_	_	_
25	transcription	transcription	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	diverse	diverse	_	_	_	_	_	_	_
28	host	host	_	_	_	_	_	_	_
29	cell	cell	_	_	_	_	_	_	_
30	types	type	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Down-regulation	down-regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	immunogenic	immunogenic	_	_	_	_	_	_	_
4	proteins	protein	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	EBNA2-EBNA6	EBNA2-EBNA6	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	nasal	nasal	_	_	_	_	_	_	_
10	lymphoma	lymphoma	_	_	_	_	_	_	_
11	may	may	_	_	_	_	_	_	_
12	enable	enable	_	_	_	_	_	_	_
13	tumour	tumour	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	evade	evade	_	_	_	_	_	_	_
17	host	host	_	_	_	_	_	_	_
18	cytotoxic	cytotoxic	_	_	_	_	_	_	_
19	T-cell	t-cell	_	_	_	_	_	_	_
20	surveillance	surveillance	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

